Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Barnett, A. H
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The challenge of tackling cardiovascular outcomes

Anthony H Barnett

Undergraduate Centre, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, B9 5SS, UK, anthony.barnett{at}heartofengland.nhs.uk

In recent years there has been a dramatic increase in the incidence of type 2 diabetes mellitus, mainly attributed to the escalating prevalence of obesity and overweight in many populations worldwide, highlighting the need to tackle dietary and physical activity factors. In people with type 2 diabetes, cardiovascular disease is the greatest cause of morbidity and premature mortality, imposing an ever-increasing burden on healthcare resources. Our improved understanding of the pathophysiology of type 2 diabetes has produced a wealth of studies in recent years, leading to substantial advances in the management of diabetes. This review will consider key landmark studies that have provided evidence to support the use of oral glucose-lowering agents, antihypertensives and lipid-lowering agents in this disease, highlighting the practical significance for clinicians.

Key Words: type 2 diabetes • cardiovascular disease • landmark studies • evidence base • clinical practice.

The British Journal of Diabetes & Vascular Disease, Vol. 6, No. 2 suppl, S12-S16 (2006)
DOI: 10.1177/14746514060060020401
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?